
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Latest articles from ONA Colorectal Cancer</title>
        <link>http://www.oncologynurseadvisor.com</link>
        <description>Latest articles from ONA Colorectal Cancer</description>
        <itunes:author>ONA</itunes:author>
        <itunes:subtitle>Colorectal Cancer</itunes:subtitle>
        <itunes:summary>Colorectal Cancer news and feature articles for oncology nurses.</itunes:summary>
        <itunes:owner>
            <itunes:name>Colorectal Cancer</itunes:name>
            <itunes:email>Admin@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.oncologynurseadvisor.com/images/2010/06/01/onalogo-mobile_103794.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Time to tumor growth best predicts survival in colorectal cancer</title>
          <description>Time to tumor growth proved to be the best metric for predicting overall survival in persons with metastatic colorectal cancer on bevacizumab.</description>
          <link>http://www.oncologynurseadvisor.com/time-to-tumor-growth-best-predicts-survival-in-colorectal-cancer/article/293685/</link>
          <pubDate>Mon, 20 May 2013 11:00:00 GMT</pubDate>
          <itunes:summary>Time to tumor growth proved to be the best metric for predicting overall survival in persons with metastatic colorectal cancer on bevacizumab.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>EGFR antagonists compared in colorectal cancer trial</title>
          <description>Phase 3 trial evaluating Vectibix vs. Erbitux for the treatment of chemo-refractory metastatic colorectal cancer meets its primary endpoint for overall survival.</description>
          <link>http://www.oncologynurseadvisor.com/egfr-antagonists-compared-in-colorectal-cancer-trial/article/292525/</link>
          <pubDate>Wed, 08 May 2013 14:56:33 GMT</pubDate>
          <itunes:summary>Phase 3 trial evaluating Vectibix vs. Erbitux for the treatment of chemo-refractory metastatic colorectal cancer meets its primary endpoint for overall survival.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Full Clinical Benefits of Regorafenib in mCRC Attainable When AEs Are Proactively Managed</title>
          <description>Adverse events associated with regorafenib are manageable with a proactive strategy that includes prophylactic treatment and education for the patient, caregiver, and healthcare provider, research presented at the ONS 38th Annual Congress has shown.</description>
          <link>http://www.oncologynurseadvisor.com/full-clinical-benefits-of-regorafenib-in-mcrc-attainable-when-aes-are-proactively-managed/article/290667/</link>
          <pubDate>Fri, 26 Apr 2013 12:48:44 GMT</pubDate>
          <itunes:summary>Adverse events associated with regorafenib are manageable with a proactive strategy that includes prophylactic treatment and education for the patient, caregiver, and healthcare provider, research presented at the ONS 38th Annual Congress has shown.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Cetuximab enables liver metastasis surgery in colorectal cancer</title>
          <description>Combining cetuximab (Erbitux) with standard therapy improved the resectability of previously inoperable liver metastases of colorectal cancer.</description>
          <link>http://www.oncologynurseadvisor.com/cetuximab-enables-liver-metastasis-surgery-in-colorectal-cancer/article/289493/</link>
          <pubDate>Mon, 22 Apr 2013 11:00:00 GMT</pubDate>
          <itunes:summary>Combining cetuximab (Erbitux) with standard therapy improved the resectability of previously inoperable liver metastases of colorectal cancer.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Virtual colonoscopy usage was Medicare-appropriate</title>
          <description>Before Medicare halted coverage for screening CT colonography in March 2009, the technique was indeed being used appropriately, a study has found.</description>
          <link>http://www.oncologynurseadvisor.com/virtual-colonoscopy-usage-was-medicare-appropriate/article/288477/</link>
          <pubDate>Tue, 16 Apr 2013 11:00:00 GMT</pubDate>
          <itunes:summary>Before Medicare halted coverage for screening CT colonography in March 2009, the technique was indeed being used appropriately, a study has found.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Anesthesia raises risk of colonoscopy complications</title>
          <description>Although the absolute risk is low, use of anesthesia for colonoscopy is associated with a somewhat higher frequency of complications.</description>
          <link>http://www.oncologynurseadvisor.com/anesthesia-raises-risk-of-colonoscopy-complications/article/284670/</link>
          <pubDate>Thu, 21 Mar 2013 11:00:00 GMT</pubDate>
          <itunes:summary>Although the absolute risk is low, use of anesthesia for colonoscopy is associated with a somewhat higher frequency of complications.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Screening colonoscopy significantly reduces the risk of advanced colorectal cancer</title>
          <description>A new study adds support to current medical recommendations stating that screening colonoscopy substantially reduced the likelihood of advanced CRC in either the right or left side of the colon being diagnosed in an average-risk adult.</description>
          <link>http://www.oncologynurseadvisor.com/screening-colonoscopy-significantly-reduces-the-risk-of-advanced-colorectal-cancer/article/284089/</link>
          <pubDate>Wed, 13 Mar 2013 13:00:00 GMT</pubDate>
          <itunes:summary>A new study adds support to current medical recommendations stating that screening colonoscopy substantially reduced the likelihood of advanced CRC in either the right or left side of the colon being diagnosed in an average-risk adult.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Lynch-related endometrial cancer raises risk of other cancers</title>
          <description>Women with Lynch syndrome and endometrial cancer have elevated risks for several other cancers, including breast, bladder, and kidney cancers.</description>
          <link>http://www.oncologynurseadvisor.com/lynch-related-endometrial-cancer-raises-risk-of-other-cancers/article/283631/</link>
          <pubDate>Mon, 11 Mar 2013 11:00:00 GMT</pubDate>
          <itunes:summary>Women with Lynch syndrome and endometrial cancer have elevated risks for several other cancers, including breast, bladder, and kidney cancers.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>New gene mutations raise colorectal cancer risk</title>
          <description>Mutations in four genes never before associated with colorectal cancer have been found to raise a person&apos;s risk for the disease by up to 40%.</description>
          <link>http://www.oncologynurseadvisor.com/new-gene-mutations-raise-colorectal-cancer-risk/article/282715/</link>
          <pubDate>Thu, 07 Mar 2013 12:00:00 GMT</pubDate>
          <itunes:summary>Mutations in four genes never before associated with colorectal cancer have been found to raise a person&apos;s risk for the disease by up to 40%.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Benchmarks for adenoma detection may be too low</title>
          <description>A recent study uncovered adenoma detection rates significantly higher than those set in national guidelines.</description>
          <link>http://www.oncologynurseadvisor.com/benchmarks-for-adenoma-detection-may-be-too-low/article/282703/</link>
          <pubDate>Tue, 05 Mar 2013 12:00:00 GMT</pubDate>
          <itunes:summary>A recent study uncovered adenoma detection rates significantly higher than those set in national guidelines.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: Efficacy &amp; Safety Study of MORAb-004 to Treat Metastatic Colorectal Cancer</title>
          <description></description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-efficacy-safety-study-of-morab-004-to-treat-metastatic-colorectal-cancer/article/243229/</link>
          <pubDate>Tue, 29 May 2012 17:10:02 GMT</pubDate>
          <itunes:summary></itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba</title>
          <description>A look at the following clinical trial: Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba</description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-innovative-tools-to-improve-colorectal-cancer-screening-rates-in-manitoba/article/207441/</link>
          <pubDate>Thu, 14 Jul 2011 16:33:22 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: Colorectal Cancer Detection by Means of Optical Fluoroscopy</title>
          <description>A look at the following clinical trial: Colorectal Cancer Detection by Means of Optical Fluoroscopy</description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-colorectal-cancer-detection-by-means-of-optical-fluoroscopy/article/207440/</link>
          <pubDate>Thu, 14 Jul 2011 16:30:24 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Colorectal Cancer Detection by Means of Optical Fluoroscopy</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: Longitudinal Study of Symptoms in Colorectal Cancer</title>
          <description>A look at the following clinical trial: Longitudinal Study of Symptoms in Colorectal Cancer</description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-longitudinal-study-of-symptoms-in-colorectal-cancer/article/207438/</link>
          <pubDate>Thu, 14 Jul 2011 16:25:05 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Longitudinal Study of Symptoms in Colorectal Cancer</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III</title>
          <description>A look at the following clinical trial: Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III</description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-combination-chemotherapy-treatments-in-patients-with-colorectal-cancer-stage-ii-and-iii/article/207436/</link>
          <pubDate>Thu, 14 Jul 2011 16:21:13 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  